
Richter joins Sofinnova from Novo Seeds
Paris-based life sciences VC Sofinnova Partners has appointed Henrijette Richter as partner.
Richter joins from Novo Seeds, where she was investment director. She spent seven years at the firm, which she helped establish in 2007 in partnership with Danish biotech behemoth Novo and the Novo Nordisk Foundation.
She holds a combined PhD and industrial scientist degree in molecular biology from the University of Copenhagen and was awarded the Anna Fuller Postdoctoral Fellowship in molecular oncology. She completed her postdoctoral fellowship at the MIT Center for Cancer Research.
While at Novo Seeds, Richter was involved in a number of biotech investments, including Affinicon, Orphazyme, EpiTherapeutics, Avilex Pharma and Lysogene – an intracerebral therapy specialist backed by Sofinnova in May this year.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater